Foot Ulcer: Clinical Trials

10 trials for Foot Ulcer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 unknown. 10 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Unknown 10
Phase 22Unknown 2

Follow Foot Ulcer: new trials by email Literature Review of Foot Ulcer trials Research Report on Foot Ulcer

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers
ADRCs, standard care, Placebo - Diabetic Foot Ulcer
Phase 3UnknownParacrine, INC.2902023-02-282022-09-28
Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer
Umbilical cord blood mononuclear cell gel(MNC), The platelet rich plasma(PRP) - Diabetic Foot Ulcer
Phase 3UnknownPeking University Third Hospital402021-03-302022-09-29
The Effect of Platelet-Rich Plasma-Fibrin Glue in Combination With Vitamin E and C for Treatment of Non-healing Diabetic Foot Ulcers
PRP-Fibrin Glue, Vitamin E and C, Placebo - Diabetic Foot Ulcers, Diabetic Wound
Phase 2 / Phase 3UnknownMashhad University of Medical Sciences242019-08-282020-03-20
Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing
Becaplermin, Promagran Dressing, Placebo Dressing - Venous Ulcer, Foot Ulcer, Diabetic
Phase 3UnknownMcMaster University802018-08-012018-04-09
Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.
recombinant human Epidermal Growth Factor (rhEGF), Placebo - Foot Ulcer, Diabetic, Epidermal Growth Factor
Phase 3UnknownThe Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)3042017-01-012023-06-15
Can Topical Oxygen Therapy (Natrox™) Improve Wound Healing in Diabetic Foot Ulcers?
Natrox™ Oxygen Delivery System (ODS) - Diabetic Foot
Phase 3UnknownUnity Health Toronto202015-12-012015-11-09
A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers
Electrohydraulic-generated shock wave, Sham device plus standard of care - Diabetic Foot Ulcers
Phase 3UnknownSANUWAVE, Inc.902013-03-012014-03-06
Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer
Dermagen® - Diabetes, Foot Ulcer
Phase 3UnknownLaboratoires Genévrier3882009-01-012010-12-15
Monochromatic Phototherapy on Diabetic Foot Ulcers
Monochromatic phototherapy, Biolight®, Monochromatic phototherapy - Diabetic Foot Ulcers
Phase 3UnknownBiolight AB1072008-08-012011-06-08
Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia
Autologous bone marrow cell concentrate transplantation, saline injection - Peripheral Vascular Disease, Diabetic Foot
Phase 2 / Phase 3UnknownFranziskus-Krankenhaus902007-04-012011-04-06

Narrower conditions

Diabetic Foot (9)  ·  Diabetes Mellitus (2)  ·  Arterial Occlusive Diseases (1)  ·  Gangrene (1)  ·  Ischemia (1)  ·  Leg Ulcer (1)  ·  Peripheral Arterial Occlusive Disease 1 (1)  ·  Peripheral Vascular Diseases (1)  ·  Ulcer (1)  ·  Varicose Ulcer (1)  ·  Wounds and Injuries (1)

Broader conditions

Endocrine System Diseases (10)  ·  Skin Diseases (10)  ·  Skin Ulcer (10)  ·  Skin and Connective Tissue Diseases (10)  ·  Cardiovascular Diseases (9)  ·  Diabetes Complications (9)  ·  Diabetic Angiopathies (9)  ·  Diabetic Neuropathies (9)  ·  Leg Ulcer (9)  ·  Vascular Diseases (9)  ·  Diabetes Mellitus (8)  ·  Glucose Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)

Interventions

Becaplermin (1)  ·  Sodium Chloride (1)  ·  Standard of Care (1)  ·  Vitamin E (1)

Sponsors

Biolight AB (1)  ·  Franziskus-Krankenhaus (1)  ·  Laboratoires Genévrier (1)  ·  Mashhad University of Medical Sciences (1)  ·  McMaster University (1)  ·  Paracrine, INC. (1)  ·  Peking University Third Hospital (1)  ·  SANUWAVE, Inc. (1)  ·  The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (1)  ·  Unity Health Toronto (1)

Countries

Canada (2)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Iran (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Berthold Amann, MD (1)  ·  Daryoush Hamidi Alamdari, Ph.D (1)  ·  Jan Apelqvist, M.D., Ph.D. (1)  ·  Long Zhang, Dr. (1)  ·  Michael Stacey, MBBS, Doctor of Surgery (1)  ·  Olivier Chosidow, MD, PhD (1)

Results publications

PMID 29703712, PMID 33646060